4D Molecular Therapeutics Inc (29)

Browse by Contract Category

Contracts

Change in Control and Severance Agreement, dated September 22, 2021, by and between Robert Stephen Fishman and 4D Molecular Therapeutics, Inc (Filed With SEC on September 24, 2021)
Description of Securities of the Registrant (Filed With SEC on March 25, 2021)
Exclusive License and Bailment Agreement, dated December 19, 2013, between the Registrant and The Regents of the University of California (Filed With SEC on December 7, 2020)
Form of Indemnification Agreement for directors and officers (Filed With SEC on December 7, 2020)
2020 Employee Stock Purchase Plan (Filed With SEC on December 7, 2020)
Change in Control and Severance Agreement, dated September 22, 2021, by and between August Moretti and 4D Molecular Therapeutics, Inc (Filed With SEC on September 24, 2021)
Change in Control and Severance Agreement, dated September 22, 2021, by and between David Kirn and 4D Molecular Therapeutics, Inc (Filed With SEC on September 24, 2021)
Form of Stock Option Grant Notice and Stock Option Agreement under the 2020 Incentive Award Plan (Filed With SEC on December 7, 2020)
Offer Letter, dated January 4, 2019 between August Moretti and the Registrant (Filed With SEC on December 7, 2020)
Employment Agreement, dated January 15, 2019 between Peter Francis, M.D., Ph.D. and the Registrant (Filed With SEC on December 7, 2020)
Offer Letter, dated March 20, 2015 between David Kirn, M.D. and the Registrant (Filed With SEC on December 7, 2020)
Exclusive License and Bailment Agreement, dated December 19, 2013, between the Registrant and The Regents of the University of California (Filed With SEC on December 7, 2020)
Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2020 Incentive Award Plan (Filed With SEC on December 7, 2020)
Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the 2020 Incentive Award Plan (Filed With SEC on December 7, 2020)
2020 Incentive Award Plan (Filed With SEC on December 7, 2020)
Amended and Restated Investors Rights Agreement, dated as of April 29, 2020, among the Registrant and the investors party thereto (Filed With SEC on December 7, 2020)
Form of Common Stock Certificate (Filed With SEC on December 7, 2020)
Form of Underwriting Agreement (Filed With SEC on December 7, 2020)
Exclusive License and Bailment Agreement, dated December 19, 2013, between the Registrant and The Regents of the University of California (Filed With SEC on November 17, 2020)
Exclusive License and Bailment Agreement, dated December 19, 2013, between the Registrant and The Regents of the University of California (Filed With SEC on November 17, 2020)
Collaboration and License Agreement, dated August 6, 2019, by and between the Registrant and uniQure biopharma B.V (Filed With SEC on November 17, 2020)
Amended and Restated Collaboration and License Agreement, dated August 6, 2019, between the Registrant and uniQure biopharma B.V (Filed With SEC on November 17, 2020)
Collaboration and License Agreement, dated November 16, 2017, among the Registrant, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc (Filed With SEC on November 17, 2020)
Form of Stock Option Agreement under 2015 Equity Incentive Plan (Filed With SEC on November 17, 2020)
2015 Equity Incentive Plan (Filed With SEC on November 17, 2020)
Amended and Restated Investors Rights Agreement, dated as of April 29, 2020, among the Registrant and the investors party thereto (Filed With SEC on November 17, 2020)
2015 Equity Incentive Plan (Filed With SEC on September 30, 2019)
Form of Stock Option Agreement under 2015 Equity Incentive Plan (Filed With SEC on September 30, 2019)
Amended and Restated Investors Rights Agreement, dated as of August 27, 2018, among the Registrant and the investors party thereto (Filed With SEC on September 30, 2019)